Technology | January 24, 2014

FDA Clears Radius Medical’s Prodigy Support Catheter

Radius Medical Prodigy Support Catheter Guidewire Cath Lab Elastomeric Balloon

January 24, 2014 — The U.S. Food and Drug Administration (FDA) cleared Radius Medical LLC’s Prodigy Support Catheter. Engineered to provide back-up support to guidewires, the Prodigy Support Catheter is intended for use in treating chronic total occlusions (CTOs).

 
The Prodigy Support Catheter is designed to stabilize catheters within vessels for enhanced guidewire pushability. The device includes an elastomeric balloon to allow for anchoring of the catheter within the vessel. The balloon material allows for a single balloon to cover vessel diameters from 2 to 6 mm.
 
"The beauty of this 5 French catheter system is that it's compatible with all conventional guiding catheters and its enhanced trackability through tortuous coronary anatomies," said Richard Heuser, M.D., chief of cardiology, St. Luke's Medical Center, Phoenix, Ariz. "What is so remarkable about this device is its soft, atraumatic balloon that provides protection against damage to the vessel wall, especially in critical cases." 
 
For more information: www.radiusmed.com 

Additional Content

News | Catheters

Nov. 4, 2026 — Evident Vascular has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident ...

Home November 05, 2026
Home
News | Catheters

Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...

Home September 15, 2026
Home
News | Catheters

June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit ...

Home July 02, 2026
Home
News | Catheters

Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...

Home February 12, 2026
Home
News | Catheters

Oct. 23, 2025— Emboline, Inc., a provider of full-body embolic protection devices for transcatheter procedures, thas ...

Home October 28, 2025
Home
Subscribe Now